CroatiaTuberculosis profile
Population  2014 4.3 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.046 (0.045–0.046) 1.1 (1.1–1.1)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 0.67 (0.28–1.2) 16 (6.6–29)
Incidence  (includes HIV+TB) 0.53 (0.46–0.59) 12 (11–14)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.09 (0.07–0.12)
         
Case detection, all forms (%) 94 (83–110)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 0 (0–1.3) 6.9 (0.85–23)
MDR-TB cases among notified pulmonary
TB cases
0 (0–6) 2 (0–8)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 346   30
Pulmonary, clinically diagnosed 74   3
Extrapulmonary 41   2
       
Total new and relapse 496    
Previously treated, excluding relapses 1    
Total cases notified 497    
Among 496 new and relapse cases:
3 (<1%) cases aged under 15 years; male:female ratio: 1.7
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 274 (79%) 29 (81%) 390
Laboratory-confirmed RR-/MDR-TB cases     2
Patients started on MDR-TB treatment ***     3
TB/HIV 2014 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (44) 516
Previously treated cases, excluding relapse, registered in 2013 (17) 6
HIV-positive TB cases, all types, registered in 2013    
RR-/MDR-TB cases started on second-line treatment in 2012    
XDR-TB cases started on second-line treatment in 2012    
Laboratories 2014  
Is second-line drug susceptibility testing available? Yes, in and outside
country
Financing TB control 2015  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-09-27 Data: www.who.int/tb/data